[split] Dimethylfumarates and Psoriasis

[Caroline]

There is a new drug for Parkinsons Disease.
Metabolite of oral DMF drug for multiple sclerosis appears to slow onset of Parkinson's disease
Published on June 9, 2016 at 7:15 AM
The metabolite of a drug that is helping patients battle multiple sclerosis appears to significantly slow the onset of Parkinson's disease, researchers say.

Source: Medical College of Georgia at Augusta University

The oral drug, dimethylfumarate, or DMF, and its metabolite, monomethylfumarate, or MMF, both increase activity of Nrf2, a protein that helps protect the body from oxidative stress and inflammation, hallmarks of both diseases, said Dr. Bobby Thomas, neuroscientist in the Department of Pharmacology and Toxicology at the Medical College of Georgia at Augusta University.